SOPH

Sophia Genetics Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 4/10
  • Value 1/10
Sophia Genetics sales and earnings growth
SOPH Growth
Neutral
  • Revenue Y/Y 18.56%
  • EPS Y/Y -23.16%
  • FCF Y/Y 17.99%
Sophia Genetics gross and profit margin trends
SOPH Profitability
Fair
  • Gross margin 67.40%
  • EPS margin -102.20%
  • ROIC 5Y -146.30%
Sophia Genetics net debt vs free cash flow
SOPH Risk
Great
  • Debt / Equity 1.3
  • Debt / FCF 0.0
  • Interest coverage -16.0

Sophia Genetics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Health Information Services stocks ↗